ID   SK-MEL-25
AC   CVCL_6028
SY   SK-Mel-25; SK-Mel 25; SK Mel 25; SK 25; AR-Mel
DR   ChEMBL-Cells; CHEMBL3308005
DR   ChEMBL-Targets; CHEMBL612706
DR   CLS; 300336
DR   PubChem_Cell_line; CVCL_6028
DR   Wikidata; Q54953979
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=6555061;
RX   PubMed=6895502;
RX   PubMed=7646526;
RX   PubMed=22970293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: CLS; 300336; true.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 22
//
RX   DOI=10.1007/978-1-4615-7228-2_39;
RA   Houghton A.N., Oettgen H.F., Old L.J.;
RT   "Malignant melanoma. Current status of the search for melanoma-specific
RT   antigens.";
RL   (In book chapter) Immunodermatology. Comprehensive Immunology, Vol 7; Safai B., Good R.A. (eds.); pp.557-576; Springer; Boston; USA (1981).
//
RX   DOI=10.1007/BF00199208;
RA   Bruggen J., Sorg C., Macher E.;
RT   "Membrane associated antigens of human malignant melanoma V:
RT   Serological typing of cell lines using antisera from nonhuman
RT   primates.";
RL   Cancer Immunol. Immunother. 5:53-62(1978).
//
RX   DOI=10.1007/BF00205883;
RA   Bruggen J., Macher E., Sorg C.;
RT   "Expression of surface antigens and its relation to parameters of
RT   malignancy in human malignant melanoma.";
RL   Cancer Immunol. Immunother. 10:121-127(1981).
//
RX   PubMed=978138; DOI=10.1084/jem.144.4.873; PMCID=PMC2190439;
RA   Shiku H., Takahashi T., Oettgen H.F., Old L.J.;
RT   "Cell surface antigens of human malignant melanoma. II. Serological
RT   typing with immune adherence assays and definition of two new surface
RT   antigens.";
RL   J. Exp. Med. 144:873-881(1976).
//
RX   PubMed=1067619; DOI=10.1073/pnas.73.9.3278; PMCID=PMC431008;
RA   Carey T.E., Takahashi T., Resnick-Silverman L.A., Oettgen H.F.,
RA   Old L.J.;
RT   "Cell surface antigens of human malignant melanoma: mixed
RT   hemadsorption assays for humoral immunity to cultured autologous
RT   melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976).
//
RX   PubMed=6555061; DOI=10.1007/BF00199165; PMCID=PMC11039250;
RA   Bruggen J., Sorg C.;
RT   "Detection of phenotypic differences on human malignant melanoma lines
RT   and their variant sublines with monoclonal antibodies.";
RL   Cancer Immunol. Immunother. 15:200-205(1983).
//
RX   PubMed=6895502; DOI=10.1002/eji.1830111015;
RA   Johnson J.P., Demmer-Dieckmann M., Meo T., Hadam M.R., Riethmuller G.;
RT   "Surface antigens of human melanoma cells defined by monoclonal
RT   antibodies. I. Biochemical characterization of two antigens found on
RT   cell lines and fresh tumors of diverse tissue origin.";
RL   Eur. J. Immunol. 11:825-831(1981).
//
RX   PubMed=7646526; DOI=10.1006/bbrc.1995.2187;
RA   Artuc M., Nurnberg W., Czarnetzki B.M., Schadendorf D.;
RT   "Characterization of gene regulatory elements for selective gene
RT   expression in human melanoma cells.";
RL   Biochem. Biophys. Res. Commun. 213:699-705(1995).
//
RX   PubMed=22970293; DOI=10.1371/journal.pone.0044707; PMCID=PMC3435279;
RA   Zhao R.Y., Mifsud N.A., Xiao K., Chan K.-F., Oveissi S., Jackson H.M.,
RA   Dimopoulos N., Guillaume P., Knights A.J., Lowen T., Robson N.C.,
RA   Russell S.E., Scotet E., Davis I.D., Maraskovsky E., Cebon J.S.,
RA   Luescher I.F., Chen W.-S.;
RT   "A novel HLA-B18 restricted CD8+ T cell epitope is efficiently
RT   cross-presented by dendritic cells from soluble tumor antigen.";
RL   PLoS ONE 7:E44707-E44707(2012).
//